insoluble in H2O; insoluble in EtOH; ≥18.9 mg/mL in DMSO
Apariencia
solid
Condiciones de almacenamiento
Store at -20°C
Indicación
Gastrointestinal ulcer
Descripción del Producto
Vonoprazan fumarate (Takecab®), discovered and developed by Takeda and Otsuka, was approved by the PMDA of Japan in December 2014, and is indicated for the treatment of gastric ulcer,
